SE0100567D0
(sv)
*
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
AU2002337442A1
(en)
*
|
2001-09-24 |
2003-04-07 |
University Of Aarhus |
Novel compositions and methods for diagnosis and treatment of lymphoma and leukemia
|
WO2003045432A1
(en)
*
|
2001-11-30 |
2003-06-05 |
Qlt, Inc. |
Treatment of neovascular ophthalmic disease
|
KR20040087335A
(ko)
*
|
2002-03-01 |
2004-10-13 |
야마노우치세이야쿠 가부시키가이샤 |
질소 함유 복소환 화합물
|
AU2003255845A1
(en)
*
|
2002-08-22 |
2004-03-11 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
WO2005023800A1
(en)
*
|
2003-09-04 |
2005-03-17 |
Warner-Lambert Company Llc |
Halo substituted benzo`b! thiophenes with pi3k inhibitory activity as therapeutic agents
|
ZA200605624B
(en)
*
|
2004-01-12 |
2007-11-28 |
Applied Research Systems |
Thiazole derivatives and use thereof
|
WO2006018735A2
(en)
*
|
2004-08-18 |
2006-02-23 |
Pharmacia & Upjohn Company Llc |
Triazolopyridine compounds
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
RU2007119637A
(ru)
*
|
2004-10-28 |
2008-12-10 |
Айрм Ллк (Bm) |
Соединения и композиции в качестве модуляторов hedgehog-пути
|
CN101098870B
(zh)
|
2004-11-08 |
2010-11-03 |
万有制药株式会社 |
新型稠环咪唑衍生物
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
CA2663528A1
(en)
*
|
2006-09-18 |
2008-03-27 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic inhibitors of c-met and uses thereof
|
EP1972631A1
(de)
*
|
2007-03-23 |
2008-09-24 |
Novartis AG |
Imidazopyridazine als PI3K-Lipidkinaseinhibitoren
|
WO2008052733A1
(en)
*
|
2006-10-30 |
2008-05-08 |
Novartis Ag |
Imidazopyridazines as pi3k lipid kinase inhibitors
|
JP2010510987A
(ja)
|
2006-11-27 |
2010-04-08 |
ハー・ルンドベック・アクチエゼルスカベット |
ヘテロアリールアミド誘導体
|
AR064106A1
(es)
*
|
2006-12-05 |
2009-03-11 |
Bayer Schering Pharma Ag |
Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida utiles para el tratamiento de enfermedades y trastornos hiper-proliferativos asociados con la angiogenesis
|
CN101502484B
(zh)
*
|
2006-12-26 |
2011-04-20 |
济南康泉医药科技有限公司 |
同载糖皮质激素和化疗药物的抗癌缓释剂
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
DK2137162T3
(en)
|
2007-03-15 |
2018-11-26 |
Novartis Ag |
Organic compounds and their applications
|
PT2137184E
(pt)
|
2007-04-03 |
2013-08-01 |
Array Biopharma Inc |
Compostos imidazo[1,2-a]piridina como inibidores do receptor de tirosina quinase
|
BRPI0809567A2
(pt)
|
2007-04-10 |
2014-09-23 |
Lundbeck & Co As H |
Composto, composição farmacêutica, método para modular a atividade de um receptor de p2x7, para tratar uma condição responsiva à modulação do receptor de p2x7 em um paciente, para inibir a morte de células do gânglio retinal em um paciente, e para determinar a presença ou ausência do receptor de p2x7 em uma amostra, preparação farmacêutica acondiciaonada, e, uso de um composto
|
CN101687873A
(zh)
*
|
2007-04-17 |
2010-03-31 |
百时美施贵宝公司 |
具有稠合杂环的11β-羟基类固醇Ⅰ型脱氢酶抑制剂
|
AU2008250328A1
(en)
*
|
2007-05-09 |
2008-11-20 |
Novartis Ag |
Substituted imidazopyridazines as PI3K lipid kinase inhibitors
|
CA2687306A1
(en)
*
|
2007-05-18 |
2008-11-27 |
Bayer Schering Pharma Aktiengesellschaft |
Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
|
KR20100049589A
(ko)
|
2007-08-14 |
2010-05-12 |
바이엘 쉐링 파마 악티엔게젤샤프트 |
암 치료를 위한 융합된 이미다졸
|
EP2062893A1
(de)
*
|
2007-10-18 |
2009-05-27 |
Bayer Schering Pharma AG |
Fusionierte Imidazole zur Behandlung von Krebs
|
KR20100065191A
(ko)
|
2007-09-14 |
2010-06-15 |
오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 |
1,3-이치환된 4-(아릴-x-페닐)-1h-피리딘-2-온
|
CN101801951B
(zh)
|
2007-09-14 |
2013-11-13 |
杨森制药有限公司 |
1’,3’-二取代的-4-苯基-3,4,5,6-四氢-2h,1’h-[1,4’]二吡啶-2’-酮
|
EP2060565A1
(de)
|
2007-11-16 |
2009-05-20 |
4Sc Ag |
Neue bifunktionelle Verbindungen die Proteinkinasen und Histonedeacetylasen hemmen
|
SG186040A1
(en)
*
|
2007-11-27 |
2012-12-28 |
Cellzome Ltd |
Amino triazoles as pi3k inhibitors
|
WO2009100375A1
(en)
|
2008-02-06 |
2009-08-13 |
Bristol-Myers Squibb Company |
Substituted imidazopyridazines useful as kinase inhibitors
|
KR20100128305A
(ko)
|
2008-02-28 |
2010-12-07 |
노파르티스 아게 |
C-met 티로신 키나제 매개 질환의 치료를 위한 이미다조[1,2-b]피리다진 유도체
|
US8394823B2
(en)
|
2008-04-11 |
2013-03-12 |
Bristol-Myers Squibb Company |
Triazolopyridine compounds useful as DGAT1 inhibitors
|
WO2009126624A1
(en)
|
2008-04-11 |
2009-10-15 |
Bristol-Myers Squibb Company |
Triazolo compounds useful as dgat1 inhibitors
|
US8134000B2
(en)
|
2008-07-14 |
2012-03-13 |
Gilead Sciences, Inc. |
Imidazolyl pyrimidine inhibitor compounds
|
US8124764B2
(en)
|
2008-07-14 |
2012-02-28 |
Gilead Sciences, Inc. |
Fused heterocyclyc inhibitor compounds
|
US8344018B2
(en)
|
2008-07-14 |
2013-01-01 |
Gilead Sciences, Inc. |
Oxindolyl inhibitor compounds
|
WO2010007099A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Cellzome Limited |
2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
US8088771B2
(en)
|
2008-07-28 |
2012-01-03 |
Gilead Sciences, Inc. |
Cycloalkylidene and heterocycloalkylidene inhibitor compounds
|
WO2010022081A1
(en)
*
|
2008-08-19 |
2010-02-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as pim kinase inhibitors
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為pim激酶抑制劑之三唑吡啶化合物
|
US8987251B2
(en)
|
2008-08-19 |
2015-03-24 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
US8895550B2
(en)
|
2008-08-19 |
2014-11-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
RU2510396C2
(ru)
|
2008-09-02 |
2014-03-27 |
Янссен Фармасьютикалз, Инк. |
3-азабицикло[3.1.0]гексильные производные в качестве модуляторов метаботропных глутаматных рецепторов
|
TWI491610B
(zh)
|
2008-10-09 |
2015-07-11 |
必治妥美雅史谷比公司 |
作為激酶抑制劑之咪唑并嗒腈
|
AU2009319387B2
(en)
|
2008-11-28 |
2012-05-10 |
Addex Pharma S.A. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
WO2010074586A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Pathway Therapeutics Limited |
Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives and their use in cancer therapy
|
EP2417135A1
(de)
|
2009-04-07 |
2012-02-15 |
Schering Corporation |
Substituierte triazolopyridine und analoga davon
|
RS53075B
(en)
|
2009-05-12 |
2014-04-30 |
Janssen Pharmaceuticals Inc. |
1,2,4-TRIAZOLO [4,3-A] PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OR PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
|
JP5707390B2
(ja)
|
2009-05-12 |
2015-04-30 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド |
1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体の正のアロステリック調節因子としてのその使用
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
JP5586692B2
(ja)
|
2009-06-08 |
2014-09-10 |
ギリアード サイエンシーズ, インコーポレイテッド |
アルカノイルアミノベンズアミドアニリンhdacインヒビター化合物
|
NZ596783A
(en)
|
2009-06-08 |
2014-01-31 |
Gilead Sciences Inc |
Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
EA201200260A1
(ru)
|
2009-08-12 |
2012-09-28 |
Новартис Аг |
Гетероциклические гидразоны и их применение для лечения рака и воспаления
|
EA201200318A1
(ru)
|
2009-08-20 |
2012-09-28 |
Новартис Аг |
Гетероциклические оксимы
|
CN106866667B
(zh)
|
2009-11-05 |
2019-11-15 |
圣母大学 |
咪唑并[1,2-a]吡啶类化合物及其合成及使用方法
|
US8741932B2
(en)
*
|
2009-11-06 |
2014-06-03 |
Piramal Enterprises Limited |
Imidazopyridine derivatives
|
EP2519522B1
(de)
*
|
2009-12-30 |
2014-09-24 |
ArQule, Inc. |
Substituierte imidazopyridinyl-aminopyridin-verbindungen
|
JP5583845B2
(ja)
|
2010-04-28 |
2014-09-03 |
ブリストル−マイヤーズ スクイブ カンパニー |
イミダゾピリダジニル化合物および癌に対するそれらの使用
|
TWI541243B
(zh)
|
2010-09-10 |
2016-07-11 |
拜耳知識產權公司 |
經取代咪唑并嗒
|
EP2649069B1
(de)
|
2010-11-08 |
2015-08-26 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazol[4,3-a]pyridinderivate und ihre verwendung als positive allosterische mglur2-rezeptormodulatoren
|
EP2643320B1
(de)
|
2010-11-08 |
2015-03-04 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridinderivate und ihre verwendung als positiv allosterische modulatoren des mglur2 receptors
|
EP2661435B1
(de)
|
2010-11-08 |
2015-08-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazol[4,3-a]pyridinderivate und ihre verwendung als positive allosterische mglur2-rezeptormodulatoren
|
WO2012068204A1
(en)
*
|
2010-11-18 |
2012-05-24 |
Janssen Pharmaceutica Nv |
Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
|
WO2012087833A1
(en)
|
2010-12-22 |
2012-06-28 |
Abbott Laboratories |
Hepatitis c inhibitors and uses thereof
|
CN102030752A
(zh)
*
|
2011-01-06 |
2011-04-27 |
贵阳中医学院 |
一种制备化合物2-(咪唑并[1,2-a]吡啶-3-基)乙腈的方法
|
US9000186B2
(en)
|
2011-02-01 |
2015-04-07 |
Kyowa Hakko Kirin Co., Ltd. |
Ring-fused heterocyclic derivative
|
EP2678329B1
(de)
|
2011-02-25 |
2015-11-18 |
Array Biopharma Inc. |
Triazolopyridin verbindungen als pim kinase hemmer
|
HUE026323T2
(en)
|
2011-04-07 |
2016-05-30 |
Bayer Ip Gmbh |
Imidazopyridazines as AKT kinase inhibitors
|
WO2012156379A1
(en)
*
|
2011-05-13 |
2012-11-22 |
Universität Zürich |
PIK3/P110α INHIBITORS FOR PREVENTION OF RESTENOSIS BY APPLICATION AS AN IMPLANT COATING
|
KR101274986B1
(ko)
*
|
2011-07-27 |
2013-06-17 |
한국과학기술원 |
이미다조피리딘 유도체, 이를 포함하는 PI3K 및/또는 mTOR 저해제용 약학 조성물 및 PI3K 및/또는 mTOR과 연관된 질환 치료용 약학 조성물
|
WO2014021383A1
(ja)
|
2012-07-31 |
2014-02-06 |
協和発酵キリン株式会社 |
縮環複素環化合物
|
US8778964B2
(en)
|
2012-11-05 |
2014-07-15 |
Bayer Pharma Aktiengesellschaft |
Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
US8796305B2
(en)
|
2012-11-05 |
2014-08-05 |
Bayer Pharma Aktiengesellschaft |
Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
US9126998B2
(en)
|
2012-11-05 |
2015-09-08 |
Bayer Pharma AG |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
MX2015006856A
(es)
*
|
2012-11-30 |
2016-02-17 |
Astellas Pharma Inc |
Compuestos imidazopiridina.
|
AP2015008663A0
(en)
|
2013-02-19 |
2015-08-31 |
Pfizer |
Azabenzimidazole compounds as inhibitors of PDE4 isozymes for the treatment of cns and other disorders
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
WO2014195333A1
(de)
*
|
2013-06-04 |
2014-12-11 |
Bayer Pharma Aktiengesellschaft |
3-aryl-substituierte imidazo[1,2-a]pyridine und ihre verwendung
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
ES2860298T3
(es)
|
2014-01-21 |
2021-10-04 |
Janssen Pharmaceutica Nv |
Combinaciones que comprenden moduladores alostéricos positivos del receptor glutamatérgico metabotrópico de subtipo 2 y su uso
|
DK3431106T3
(da)
|
2014-01-21 |
2021-03-15 |
Janssen Pharmaceutica Nv |
Kombinationer omfattende positive allosteriske modulatorer eller orthosteriske agonister af metabotrop glutamaterg subtype 2-receptor og anvendelse af disse
|
ME03580B
(de)
|
2014-02-13 |
2020-07-20 |
Incyte Corp |
Cyclopropylamine als lsd1-hemmer
|
CA2939082C
(en)
|
2014-02-13 |
2022-06-07 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
ES2672797T3
(es)
|
2014-02-13 |
2018-06-18 |
Incyte Corporation |
Ciclopropilaminas como inhibidores de LSD1
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
CA2939793A1
(en)
|
2014-02-19 |
2015-08-27 |
Bayer Pharma Aktiengesellschaft |
3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines
|
WO2015140199A1
(de)
|
2014-03-21 |
2015-09-24 |
Bayer Pharma Aktiengesellschaft |
Cyano-substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
|
CA2938923A1
(en)
*
|
2014-03-24 |
2015-10-01 |
Arqule Inc. |
Process of preparing 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3h-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine
|
DK3134407T3
(da)
*
|
2014-04-22 |
2019-09-23 |
Arqule Inc |
Salte og polymorfer af en substitueret imidazopyridinyl-aminopyridinforbindelse
|
US20170057958A1
(en)
|
2014-05-02 |
2017-03-02 |
Bayer Pharma Aktiengesellschaft |
Enantiomers of the n-(2-amino-5-fluoro-2-methylpentyl)-8-[(2,6-difluorobenzyl)oxy]-2-methylimidazo[1,2-a]pyridine-3-carboxamide, as well as of the di- and trifluoro derivatives for the treatment of cardiovascular diseases
|
WO2016007727A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
WO2016007731A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyridines and imidazopyrazines as lsd1 inhibitors
|
TW201613925A
(en)
|
2014-07-10 |
2016-04-16 |
Incyte Corp |
Imidazopyrazines as LSD1 inhibitors
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
JP6713982B2
(ja)
|
2014-07-24 |
2020-06-24 |
ファイザー・インク |
ピラゾロピリミジン化合物
|
CU20170007A7
(es)
|
2014-08-06 |
2017-06-05 |
Pfizer |
Compuestos de imidazopiridazina
|
JP2017536396A
(ja)
|
2014-12-02 |
2017-12-07 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
ヘテロアリール置換イミダゾ[1,2−a]ピリジンおよびその使用
|
TWI714567B
(zh)
|
2015-04-03 |
2021-01-01 |
美商英塞特公司 |
作為lsd1抑制劑之雜環化合物
|
CR20180152A
(es)
|
2015-08-12 |
2018-08-09 |
Incyte Corp |
Sales de un inhibidor de lsd1
|
CA2998375A1
(en)
|
2015-09-17 |
2017-03-23 |
Marvin J. Miller |
Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection
|
GB201602527D0
(en)
*
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
WO2017181973A1
(zh)
*
|
2016-04-20 |
2017-10-26 |
苏州苏领生物医药有限公司 |
五元杂环类化合物及其制备方法、药物组合物和用途
|
CN107304202A
(zh)
*
|
2016-04-20 |
2017-10-31 |
苏州苏领生物医药有限公司 |
五元杂环类化合物及其制备方法、药物组合物和用途
|
MX2018012901A
(es)
|
2016-04-22 |
2019-06-06 |
Incyte Corp |
Formulaciones de inhibidor de demetilasa 1 especifica para lisina (lsd1).
|
WO2017197151A1
(en)
|
2016-05-11 |
2017-11-16 |
Emory University |
Phosphotidylinositol 3-kinase inhibitors
|
US11352328B2
(en)
|
2016-07-12 |
2022-06-07 |
Arisan Therapeutics Inc. |
Heterocyclic compounds for the treatment of arenavirus
|
WO2018184976A1
(de)
|
2017-04-05 |
2018-10-11 |
Bayer Pharma Aktiengesellschaft |
Substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
|
AU2018354785A1
(en)
|
2017-10-24 |
2020-04-23 |
Bayer Aktiengesellschaft |
Substituted imidazopyridine amides and use thereof
|
WO2020047198A1
(en)
|
2018-08-31 |
2020-03-05 |
Incyte Corporation |
Salts of an lsd1 inhibitor and processes for preparing the same
|
JP2022526901A
(ja)
|
2019-03-19 |
2022-05-27 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
駆虫性アザベンゾチオフェンおよびアザベンゾフラン化合物
|
WO2020216669A1
(de)
|
2019-04-23 |
2020-10-29 |
Bayer Aktiengesellschaft |
Phenylsubstituierte imidazopyridinamide und ihre verwendung
|
KR20220162155A
(ko)
*
|
2020-04-27 |
2022-12-07 |
주식회사 오토텍바이오 |
Ubr 박스 도메인 리간드로의 화합물
|
PE20231205A1
(es)
|
2020-05-29 |
2023-08-17 |
Boehringer Ingelheim Animal Health Usa Inc |
Compuestos heterociclicos como anthelminticos
|
CN113135913B
(zh)
*
|
2021-04-28 |
2022-05-24 |
沈阳药科大学 |
3-取代基-6-吡啶类取代基-六元并五元杂环类衍生物及其制法与用途
|